MX350519B - Metodo para la preparacion de compuestos de triazol. - Google Patents
Metodo para la preparacion de compuestos de triazol.Info
- Publication number
- MX350519B MX350519B MX2014013448A MX2014013448A MX350519B MX 350519 B MX350519 B MX 350519B MX 2014013448 A MX2014013448 A MX 2014013448A MX 2014013448 A MX2014013448 A MX 2014013448A MX 350519 B MX350519 B MX 350519B
- Authority
- MX
- Mexico
- Prior art keywords
- preparation
- pyrimidino
- pyrazolo
- morpholino
- triazole compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12167152 | 2012-05-08 | ||
| PCT/EP2013/059418 WO2013167552A1 (de) | 2012-05-08 | 2013-05-06 | Verfahren zur herstellung von triazol-verbindungen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014013448A MX2014013448A (es) | 2014-12-08 |
| MX350519B true MX350519B (es) | 2017-09-08 |
Family
ID=48325714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014013448A MX350519B (es) | 2012-05-08 | 2013-05-06 | Metodo para la preparacion de compuestos de triazol. |
Country Status (35)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2639716B2 (ja) | 1988-12-14 | 1997-08-13 | 横浜ゴム株式会社 | タイヤ成形装置に於けるグリーンタイヤの搬送装置 |
| JOP20170103A1 (ar) * | 2016-05-03 | 2017-11-03 | Bayer Pharma AG | عملية لتحضير مشتقات 1-فنيل-1، 2، 4-تريازول مستبدلة بـ 5-هيدروكسي ألكيل |
| CN108084099B (zh) * | 2017-12-20 | 2019-01-29 | 天驰药业有限公司 | 一种1,2,3-三氮唑化合物的合成方法 |
| US10702525B1 (en) | 2019-09-04 | 2020-07-07 | United Arab Emirates University | Pyrimidine derivatives as anti-diabetic agents |
| EP3888684A1 (en) | 2020-03-31 | 2021-10-06 | Bayer Animal Health GmbH | Composition having improved voluntary acceptance |
| JP7710897B2 (ja) * | 2021-06-01 | 2025-07-22 | 三菱ガス化学ネクスト株式会社 | １－アルキル－５－ヒドロキシピラゾールの製造方法 |
| CN114264752B (zh) * | 2021-12-29 | 2023-08-15 | 北京金城泰尔制药有限公司 | 溴乙酸甲酯的检测方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK135184A (da) | 1983-03-03 | 1984-10-10 | Riker Laboratories Inc | Triazol(4,3-c)- og triazol(1,5-c)pyrimidiner |
| US4572910A (en) * | 1983-03-03 | 1986-02-25 | Riker Laboratories, Inc. | Triazolo[1,5-c]pyrimidines substituted by nitrogen-containing heterocyclic rings |
| US4752910A (en) | 1984-10-30 | 1988-06-21 | Prime Computer, Inc. | Method and apparatus for continuous after-imaging |
| UY27813A1 (es) * | 2002-05-31 | 2003-12-31 | Smithkline Beecham Corp | Inhibidores de la peptido-desformilasa |
| CL2003002353A1 (es) | 2002-11-15 | 2005-02-04 | Vertex Pharma | Compuestos derivados de diaminotriazoles, inhibidores d ela proteina quinasa; composicion farmaceutica; procedimiento de preparacion; y su uso del compuesto en el tratamiento de enfermedades de desordenes alergicos, proliferacion, autoinmunes, condic |
| WO2005044785A1 (en) * | 2003-10-30 | 2005-05-19 | Merck & Co., Inc. | Aralkyl amines as cannabinoid receptor modulators |
| US7745630B2 (en) | 2003-12-22 | 2010-06-29 | Justin Stephen Bryans | Triazolyl piperidine arginine vasopressin receptor modulators |
| DE102008020113A1 (de) | 2008-04-23 | 2009-10-29 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Dihydropyrazolone und ihre Verwendung |
| EP1877399A1 (en) | 2005-04-26 | 2008-01-16 | Pfizer Limited | Triazole derivatives as vasopressin antagonists |
| CA2608718A1 (en) | 2005-05-18 | 2006-11-23 | Pfizer Limited | 1, 2, 4-triazole derivatives as vasopressin antagonists |
| DE102006050516A1 (de) * | 2006-10-26 | 2008-04-30 | Bayer Healthcare Ag | Substituierte Dihydropyrazolone und ihre Verwendung |
| DE102010041236A1 (de) * | 2010-09-23 | 2012-03-29 | Osram Ag | Optoelektronisches Halbleiterbauelement |
| DE102010044131A1 (de) * | 2010-11-18 | 2012-05-24 | Bayer Schering Pharma Aktiengesellschaft | Substituiertes Natrium-1H-pyrazol-5-olat |
-
2013
- 2013-05-06 AU AU2013258107A patent/AU2013258107B2/en active Active
- 2013-05-06 EP EP13720943.3A patent/EP2847183B1/de active Active
- 2013-05-06 WO PCT/EP2013/059418 patent/WO2013167552A1/de not_active Ceased
- 2013-05-06 HU HUE13720943A patent/HUE034430T2/en unknown
- 2013-05-06 RS RS20170869A patent/RS56255B1/sr unknown
- 2013-05-06 SG SG10201609319YA patent/SG10201609319YA/en unknown
- 2013-05-06 MX MX2014013448A patent/MX350519B/es active IP Right Grant
- 2013-05-06 ES ES13720943.3T patent/ES2641205T3/es active Active
- 2013-05-06 PL PL13720943T patent/PL2847183T3/pl unknown
- 2013-05-06 JP JP2015510775A patent/JP6149104B2/ja active Active
- 2013-05-06 HR HRP20171321TT patent/HRP20171321T1/hr unknown
- 2013-05-06 CN CN201380036548.5A patent/CN104411704B/zh active Active
- 2013-05-06 SI SI201330768T patent/SI2847183T1/sl unknown
- 2013-05-06 DK DK13720943.3T patent/DK2847183T3/en active
- 2013-05-06 BR BR112014027564-5A patent/BR112014027564B1/pt active IP Right Grant
- 2013-05-06 PT PT137209433T patent/PT2847183T/pt unknown
- 2013-05-06 AP AP2014008089A patent/AP2014008089A0/xx unknown
- 2013-05-06 PE PE2014001942A patent/PE20142453A1/es active IP Right Grant
- 2013-05-06 US US14/399,929 patent/US10301289B2/en active Active
- 2013-05-06 EA EA201492032A patent/EA027804B1/ru not_active IP Right Cessation
- 2013-05-06 SG SG11201407043PA patent/SG11201407043PA/en unknown
- 2013-05-06 MY MYPI2014703274A patent/MY184577A/en unknown
- 2013-05-06 LT LTEP13720943.3T patent/LT2847183T/lt unknown
- 2013-05-06 KR KR1020147033989A patent/KR102086389B1/ko active Active
- 2013-05-06 CA CA2872726A patent/CA2872726C/en active Active
- 2013-05-06 UA UAA201413001A patent/UA116349C2/uk unknown
- 2013-05-06 NZ NZ701661A patent/NZ701661A/en unknown
-
2014
- 2014-11-02 IL IL235441A patent/IL235441A/en active IP Right Grant
- 2014-11-04 CO CO14243310A patent/CO7121324A2/es unknown
- 2014-11-06 CL CL2014003003A patent/CL2014003003A1/es unknown
- 2014-11-06 CU CU2014000128A patent/CU20140128A7/es unknown
- 2014-11-06 PH PH12014502482A patent/PH12014502482A1/en unknown
- 2014-11-07 TN TN2014000469A patent/TN2014000469A1/fr unknown
- 2014-11-07 CR CR20140514A patent/CR20140514A/es unknown
- 2014-11-07 DO DO2014000254A patent/DOP2014000254A/es unknown
- 2014-11-21 ZA ZA2014/08571A patent/ZA201408571B/en unknown
-
2016
- 2016-05-13 CL CL2016001165A patent/CL2016001165A1/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2014000469A1 (en) | Method for the preparation of triazole compounds | |
| MX2015008927A (es) | Proceso para la preparacion de oxiranos y triazoles sustituidos. | |
| JO3062B1 (ar) | R)-(e)-2-(4-(2-(5-(1-(3، 5-داي كلورو بيريدين-4-يل)إيثوكسي)-1h-إندازول-3-يل)?ينيل)-1h-بيرازول-1-يل)إيثانول بلوري | |
| MX381205B (es) | Acidos de carbamoiloximetil triazol ciclohexilo como antagonistas de acido lisofosfatidico (lpa). | |
| SA113340696B1 (ar) | تصنيع 2-(5-برومو-4-(4-سيكلو بروبيل نافثالين-1-يل)-4 h-1، 2، 4- ترازول-3- يل ثيو) حمض أسيتيك | |
| TN2014000155A1 (en) | Substituted tetrahydroisoquinoline compounds as factor xia inhibitors | |
| MX2020005818A (es) | Triazol azoles de acido ciclohexilo como antagonistas de acido lisofosfatidico (lpa). | |
| CL2014000201A1 (es) | Compuestos fungicidas de 1-(2-(2-halo-4-(4-halogen-fenoxi)-fenil)-2-aluiniloxi-etil)-1h-(1,2,4)triazol sustituidos; procesos para preparar dichos compuestos; uso de dichos compuestos para combatir hongos fitopatógenos. | |
| PH12012501510A1 (en) | 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates | |
| WO2011110583A3 (en) | Fungicidal mixtures comprising triazole derivatives | |
| NZ627113A (en) | Substituted pyrimidine compounds and their use as syk inhibitors | |
| IL259439A (en) | 4-((6-(4,2-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1h -4,2,1-triazol-1-yl)propyl)pyridin-3-yl)oxy ) Benzonitrile and processes for its preparation | |
| ZA201803745B (en) | 4-((6-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation | |
| MX2009012228A (es) | Compuesto de triazolil aminopirimidina. | |
| MX2015000980A (es) | Inhibidores de aril lactama cinasa. | |
| NZ610614A (en) | Substituted sodium-1h-pyrazole-5-olate | |
| EP3541796A4 (en) | 4 - ((6- (2,4-DIFLUORPHENYL) -1,1-DIFLUOR-2-HYDROXY-3- (5-MERCAPTO-1H | |
| MX2021002132A (es) | Metodo para preparar 2-[(3r)-3--metilmofolin--4-il]-4-(1-metil-1h- pirazol-5-il)-8-(1h-pirazol-5-il)-1,7-naftiridina. | |
| EP3233824A4 (en) | (s)-n-(3-(6-isopropoxypyridin-3-yl)-1h-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2h)-yl)-2-oxoethyl)-3- (methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations | |
| JO3485B1 (ar) | 4- {4-[(1e)-4-( 2 , 9- داي ازا سبيرو ] 5.5 [ انديك- 2- يل )بيوت -1 – ين-1-يل[ -2-ميثيل بنزيل {- 5-(بروبان-2-يل)- 1h-بيرازول -3-يل بيتا – d – جلوكو بيرانوسيد اسيتيت | |
| EP3233079A4 (en) | (s)-n-(3-(6-isopropoxypyridin-3-yl)-1h-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2h)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations | |
| TH152857A (th) | วิธีการสำหรับการเตรียมของสารประกอบไตรอาซอล | |
| IL244933B (en) | Pharmaceutical dosage forms containing sodium 1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(3,2,1-1h-triazol-1-yl)-1h-pyrazol-5-olate | |
| TR201105728A2 (tr) | 2-(2,4-diflorofenil)-1,3-bis(1h-1,2,4-triazol-1-il)propan-2 ol'ün farmasotik bir bileşim içerisinde kullanımı. | |
| LV14757A (lv) | Arabinofuranozilpurīna nukleozīdu sintēze |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |